Bone Diseases: Clinical Trials

99 trials for Bone Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

99 terminated. 99 Phase 2, 15 Phase 1, 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 299Terminated 99
Phase 115Terminated 15
Phase 38Terminated 8

Follow Bone Diseases: new trials by email Literature Review of Bone Diseases trials Research Report on Bone Diseases

Trials (filtered) newest first · largest first

All 99 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)
GS3-007a dry suspension, Insulin - Adult Growth Hormone Deficiency (AGHD)
Phase 2TerminatedChangchun GeneScience Pharmaceutical Co., Ltd.1202025-12-192026-05-22
ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
ALXN2420, Placebo - Acromegaly
Phase 2TerminatedAlexion Pharmaceuticals, Inc.82025-10-282026-08-07
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
Vosoritide Injection - Noonan Syndrome
Phase 2TerminatedBioMarin Pharmaceutical182024-11-222026-11-13
Bone in CKD Alkali Response (BICARb Pilot Trial)
Potassium Citrate Extended Release Oral Tablet, Placebo, Potassium Citrate and Citric Acid Oral Solution - Chronic Kidney Diseases, Bone Loss
Phase 2 / Phase 3TerminatedAlbert Einstein College of Medicine62024-08-152026-07-28
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia
SAR442501 - Osteochondrodysplasia
Phase 2TerminatedSanofi162023-10-102026-06-25
VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)
Dose A VTX958, Dose B VTX958, Placebo - Psoriatic Arthritis
Phase 2TerminatedVentyx Biosciences, Inc2052023-01-312024-12-27
Psoriatic Arthritis Study of Izokibep
Izokibep, Placebo to izokibep - Psoriatic Arthritis
Phase 2 / Phase 3TerminatedACELYRIN Inc.3512022-11-212025-05-23
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
ATI-450, Placebo Oral Tablet - Psoriatic Arthritis
Phase 2TerminatedAclaris Therapeutics, Inc.472022-07-122024-11-27
Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis
Cannabis: placebo and medium THC/medium CBD - Rheumatoid Arthritis, Psoriatic Arthritis
Phase 2TerminatedBrown University32022-05-182025-04-01
Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis Imperfecta
Setrusumab - Osteogenesis Imperfecta
Phase 2TerminatedUltragenyx Pharmaceutical Inc22022-04-282025-07-23
Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA
JS005, Placebo - Non-radiographic Axial Spondyloarthritis
Phase 2TerminatedShanghai Junshi Bioscience Co., Ltd.232021-12-312026-07-21
Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia
Recifercept - Achondroplasia
Phase 2TerminatedPfizer352021-12-242024-02-08
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
Bacteriophage Therapy, Placebo - Osteomyelitis, Diabetic Foot Osteomyelitis
Phase 2TerminatedAdaptive Phage Therapeutics, Inc.412021-11-242025-08-19
Effect of GLP-1 Receptor Agonists on Trabecular Bone Score
GLP-1 receptor agonist - Osteoporosis, Postmenopausal, Diabetes Mellitus, Type 2
Phase 2TerminatedUniversity of Mississippi Medical Center52021-11-092025-06-13
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
5-Aminolevulinic acid Hydrochloride - Neoplasm, Skull Base Neoplasm
Phase 2TerminatedIcahn School of Medicine at Mount Sinai72021-09-142025-07-28
A Study of CC-99677 in Participants With Active Ankylosing Spondylitis
CC-99677, Placebo - Spondylitis, Ankylosing
Phase 2TerminatedCelgene1672021-08-252024-05-01
ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
ABY-035, Placebo - Ankylosing Spondylitis
Phase 2TerminatedInmagene LLC252021-08-242023-07-12
A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia
Recifercept - Achondroplasia
Phase 2TerminatedPfizer602020-12-022024-02-15
A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma
Bintrafusp alfa (M7824) - Urothelial Cancer
Phase 2TerminatedNational Cancer Institute (NCI)22020-10-262022-03-22
Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma
Derazantinib, Derazantinib-paclitaxel-ramucirumab combination - Gastric Adenocarcinoma
Phase 1 / Phase 2TerminatedBasilea Pharmaceutica472020-10-062024-04-04

Showing 20 of 99. Sign in to see all of them.

Narrower conditions

Osteoporosis (13)  ·  Arthritis, Psoriatic (11)  ·  Dwarfism, Pituitary (10)  ·  Spondylitis, Ankylosing (7)  ·  Camurati-Engelmann Syndrome (6)  ·  Dwarfism (6)  ·  Acrocephalosyndactylia (5)  ·  Arthritis (5)  ·  Bone Neoplasms (5)  ·  Acromegaly (4)  ·  Bone Diseases, Metabolic (4)  ·  Diabetes Mellitus (4)  ·  Musculoskeletal Diseases (4)  ·  Psoriasis (4)

Broader conditions

Musculoskeletal Diseases (95)  ·  Bone Diseases, Developmental (36)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (27)  ·  Spinal Diseases (27)  ·  Endocrine System Diseases (26)  ·  Nutritional and Metabolic Diseases (26)  ·  Metabolic Diseases (25)  ·  Skin and Connective Tissue Diseases (23)  ·  Joint Diseases (22)  ·  Genetic Diseases, Inborn (21)  ·  Spondylarthritis (20)  ·  Spondylitis (20)  ·  Nervous System Diseases (19)  ·  Pathological Conditions, Signs and Symptoms (19)

Interventions

Gemcitabine (3)  ·  Human Growth Hormone (3)  ·  Saline Solution (3)  ·  Zoledronic Acid (3)  ·  Alendronate (2)  ·  Calcium Carbonate (2)  ·  Denosumab (2)  ·  Growth Hormone (2)  ·  Growth Hormone-Releasing Hormone (2)  ·  Irinotecan (2)  ·  Teriparatide (2)  ·  Vitamin D (2)  ·  pembrolizumab (2)  ·  pemigatinib (2)  ·  sonidegib (2)

Sponsors

Pfizer (5)  ·  National Cancer Institute (NCI) (3)  ·  Advanced Accelerator Applications (2)  ·  Bristol-Myers Squibb (2)  ·  Incyte Corporation (2)  ·  Ipsen (2)  ·  Sanofi (2)  ·  Versartis Inc. (2)  ·  ACELYRIN Inc. (1)  ·  AbbVie (1)  ·  Aclaris Therapeutics, Inc. (1)  ·  Adaptive Phage Therapeutics, Inc. (1)  ·  Albert Einstein College of Medicine (1)  ·  Alexion Pharmaceuticals, Inc. (1)  ·  Allergan (1)

Countries

United States (74)  ·  Spain (22)  ·  Poland (16)  ·  Germany (15)  ·  Belgium (14)  ·  Italy (13)  ·  Australia (12)  ·  France (12)  ·  Canada (10)  ·  United Kingdom (10)  ·  Czechia (8)  ·  Hungary (8)  ·  China (6)  ·  Denmark (6)  ·  Netherlands (6)

Top investigators

Dariush Elahi, PhD (2)  ·  Will Charlton, MD (2)  ·  Aditi Mehta, DO (1)  ·  Alfred-Marc Iloreta, MD (1)  ·  Alfredo Addeo, MD (1)  ·  Andrea B Apolo, M.D. (1)  ·  Andrew Gilman, MD (1)  ·  Andrew M Scott, MBBS (1)  ·  Anne Lynn Chang, MD (1)  ·  Antonio A Lazzari, MD (1)

Results publications

PMID 19654233, PMID 21128258, PMID 21593114, PMID 25166719, PMID 25968622, PMID 26773108, PMID 26828618, PMID 28735378, PMID 29175429, PMID 29296761, PMID 30032191, PMID 32461347, PMID 35137002, PMID 35727196, PMID 37162744, PMID 38685585, PMID 38710951, PMID 38875119, PMID 39665575, PMID 39722695, PMID 40648907, PMID 40676732, PMID 41188357, PMID 42167889

NIH funding

2019 (4), 2009 (3), 2017 (3), 2023 (2), 2014 (1), 2015 (1), 2016 (1), 2018 (1), I01RX001449 (1), KL2TR003168 (1), P01AG000599 (1), P20GM130414 (1), R01DK131811 (1)